raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:552

MODY

Synonyms: Maturity-onset diabetes of the young

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant, Not applicable
Age of onset
Adolescent, Adult, Childhood
Status
active

MODY (maturity-onset diabetes of the young) is a rare, familial, clinically and genetically heterogeneous form of diabetes characterized by young age of onset (generally 10-45 years of age) with maintenance of endogenous insulin production, lack of pancreatic beta-cell autoimmunity, absence of obesity and insulin resistance and extra-pancreatic manifestations in some subtypes.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enMODYMaturity-onset diabetes of the young
frMODYDiabète juvénile
deMODY
esMODYDiabetes de la edad madura que se presenta en el joven · Diabetes del adulto de inicio juvenil · Diabetes del adulto joven
itMODYDiabete giovanile a esordio nella maturità
nlMODYOuderdomsdiabetes op jonge leeftijd
ptSíndrome MODYDiabetes juvenil com início tardio
plMODYCukrzyca typu MODY
csMODYDiabetes dospělého typu objevující se u mladých lidí
ukМОDYЦукровий діабет у молодих людей, що починається в зрілому віці
zh青少年成人起病型糖尿病年轻的成年发病型糖尿病
trMODYGençlerin erişkin-başlangıçlı diyabeti

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM125850BTNTvalidated
OMIM125851BTNTvalidated
OMIM600496BTNTvalidated
OMIM606392BTNTvalidated
OMIM606394BTNTvalidated
OMIM609812BTNTvalidated
OMIM610508BTNTvalidated
OMIM612225BTNTvalidated
OMIM613370BTNTvalidated
OMIM613375BTNTvalidated
OMIM616329BTNTvalidated
OMIM616511BTNTvalidated
ICD-10E13.9NTBTattributedvalidated
ICD-115A13.6NTBTindexvalidated
MONDO0018911Evalidated
MeSHC562772Evalidated
UMLSC0342276Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

13 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
APPL1Disease-causing germline mutation(s) (loss of function) inAssessedHGNC:24035ENSG000001575006042993p14.3adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 126073777[PMID]
ABCC8Disease-causing germline mutation(s) inAssessedHGNC:59ENSG0000000607160050911p15.1ATP binding cassette subfamily C member 821989597[PMID]
BLKDisease-causing germline mutation(s) inAssessedHGNC:1057ENSG000001365731913058p23.1BLK proto-oncogene, Src family tyrosine kinase19667185[PMID]
CELDisease-causing germline mutation(s) inAssessedHGNC:1848ENSG000001708351148409q34.13carboxyl ester lipase21844708[PMID]
GCKDisease-causing germline mutation(s) inAssessedHGNC:4195ENSG000001066331380797p13glucokinase21844708[PMID]_22498247[PMID]
HNF1ADisease-causing germline mutation(s) inAssessedHGNC:11621ENSG0000013510014241012q24.31HNF1 homeobox A21844708[PMID]_22498247[PMID]
HNF4ADisease-causing germline mutation(s) inAssessedHGNC:5024ENSG0000010107660028120q13.12hepatocyte nuclear factor 4 alpha21844708[PMID]_22498247[PMID]
INSDisease-causing germline mutation(s) inAssessedHGNC:6081ENSG0000025464717673011p15.5insulin22498247[PMID]
KCNJ11Disease-causing germline mutation(s) inAssessedHGNC:6257ENSG0000018748660093711p15.1potassium inwardly rectifying channel subfamily J member 1122701567[PMID]
KLF11Disease-causing germline mutation(s) inAssessedHGNC:11811ENSG000001720596033012p25.1KLF transcription factor 1121844708[PMID]
NEUROD1Disease-causing germline mutation(s) inAssessedHGNC:7762ENSG000001629926017242q31.3neuronal differentiation 121844708[PMID]_22498247[PMID]
PAX4Disease-causing germline mutation(s) inAssessedHGNC:8618ENSG000001063311674137q32.1paired box 417426099[PMID]_21263211[PMID]_22521316[PMID]_25041077[PMID]
PDX1Disease-causing germline mutation(s) inAssessedHGNC:6107ENSG0000013951560073313q12.2pancreatic and duodenal homeobox 121844708[PMID]_22498247[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Point prevalence1-5 / 10 000—EuropeClass onlyValidatedORPHANET
Point prevalence1-5 / 10 00010 / 100 000United KingdomValue and classValidated20499044[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

27 annotations · validated 2019-05-02
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0030794Abnormal C-peptide level
HP:0040214Abnormal circulating insulin concentration
HP:0004924Abnormal oral glucose tolerance
HP:0040217Elevated hemoglobin A1c
HP:0001952Glucose intolerance
HP:0003076Glycosuria
HP:0003074Hyperglycemia
HP:0040216Hypoinsulinemia
Occasional (29-5%)
HP:0000825Hyperinsulinemic hypoglycemia
HP:0000831Insulin-resistant diabetes mellitus
HP:0001511Intrauterine growth retardation
HP:0001520Large for gestational age
HP:0001998Neonatal hypoglycemia
HP:0000112Nephropathy
HP:0025502Overweight
HP:0000488Retinopathy
HP:0008255Transient neonatal diabetes mellitus
Very rare (<4-1%)
HP:0000119Abnormality of the genitourinary system
HP:0000077Abnormality of the kidney
HP:0001738Exocrine pancreatic insufficiency
HP:0012028Hepatocellular adenoma
HP:0001513Obesity
HP:0002594Pancreatic hypoplasia
HP:0000107Renal cyst
Excluded (0%)
HP:0000956Acanthosis nigricans
HP:0030057Autoimmune antibody positivity
HP:0001953Diabetic ketoacidosis

Annotation source: 15784703[PMID]_22701567[PMID]_16369531[PMID]_4212169[PMID]_11575290[PMID]_29792621[PMID]

7

Sources for this card